Ads
related to: fda stem cell therapy
Search results
FDA Warns Company Making Stem Cell Products for Pets
MedPage Today· 3 days agoFDA has sent a warning letter to a company that makes stem cell and platelet-rich plasma products -- for pets. The agency told Texas-based ...
Stem Cells Fast Facts
KEYT 3 Santa Barbara· 2 days agoScientists believe that stem cell research can be used to treat medical conditions including Parkinson’s disease, spinal cord injury, stroke, burns,...
Gene therapy and employee benefits: from science fiction to medical reality
BenefitsPRO· 4 days agoAt the rate research and approvals have been accelerating, the 2020s may be remembered as the decade...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 4 days agoBioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today ...
CARVYKTI® (ciltacabtagene autoleucel) significantly improved progression-free survival and deepened...
Forrest City Times-Herald· 4 days agoJohnson & Johnson announced today results from a subgroup analysis of the Phase 3 CARTITUDE-4 study. Data from the CARTITUDE-4 study supported the recent U.S. FDA approval ...
Allen Institute's cell lines could lead to new drugs for hypertrophic cardiomyopathy
FierceBiotech· 3 days agoNow, the Allen Institute for Cell Science has taken a step toward solving the problem with six new...
Seres sells VOWST assets to Nestlé Health Science By Investing.com
Investing.com· 1 day agoThe deal will see Seres receive an upfront payment along with additional financial considerations,...
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 6 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant
HIV/AIDS Fast Facts
KEYT 3 Santa Barbara· 2 days agoCNN Editorial Research (CNN) — Here’s a look at the origins, treatments and global response to HIV and AIDS.FactsHIV stands for human
TECVAYLI® (teclistamab-cqyv) shows sustained deep and durable responses in patients with relapsed or...
Forrest City Times-Herald· 4 days ago"With the longest follow-up of any bispecific antibody, teclistamab demonstrates continued deep and durable responses observed in patients with relapsed or refractory multiple myeloma who have ...
